Synthego

Synthego is a CRISPR company that enables life science research and the development of new therapeutics and genomic medicines. Our mission is to increase access to CRISPR-based technologies and therapeutics for all scientists and patients. With unparalleled CRISPR expertise, state-of-the-art GMP capabilities, and a continuum of product offerings, Synthego supports the development of new therapeutics and genomic medicines at every step, from optimization through IND submission to first-in-human clinical trials.